We sit down with you and build your perfect lead list. Book a call with founders.

Pyrls Analysis: $500K Raised

What is Pyrls?

Pyrls offers a platform for clinicians and trainees to access drug information, including medication summaries, pharmacotherapy reviews, and drug interaction tools.
Founded
2020
Revenue
$1-5M
Company Stage
Pre-Seed
Investors
  • Y Combinator
  • Coho Deeptech
YC Batch
W22

Product Features & Capabilities

  • Drug Summaries, Pharmacotherapy Reviews, Knowledge Check Assessments, Drug-Drug Interactions Tools, Fully-Automated Keyword Grouping, Backed By 15 Billion Keywords.

How much Pyrls raised

Pre-Seed - $500,000

March 22, 2022
Lead Investor: Y Combinator

Who are the founders of Pyrls

Company Pricing

  • Pyrls Free: Free forever, no credit card required
  • Pyrls Pro: $15 per month paid yearly or $40 per month paid

Find more companies like Pyrls

YC W22 - Winter 2022

See something that needs updating? Suggest edits to this profile.

Financial Overview

$1-5MEstimated Revenue
$500KTotal Raised
Pre-Seed$500,000
March 22, 2022
Investors: Y Combinator
Want to research more data points on Pyrls?
Start with Extruct